All News #Library
Rare Diseases
Edgewise Gets EMA Orphan Designation for Muscular Dystrophies Drug
23 Apr 2024 //
BUSINESSWIRE
Edgewise Receives Orphan Drug Designations for Its Muscular Dystrophy Program
30 Nov 2023 //
BUSINESSWIRE

Market Place
Sourcing Support